Composition for treating infantile eczema, preparation, preparation method of preparation, and application of composition

A technology of infant eczema and composition, applied in the field of medicine, can solve the problems of telangiectasia, pigmentation, skin atrophy, etc., and achieve the effect of reducing congestion and alleviating inflammatory reactions

Inactive Publication Date: 2019-02-01
上海松皓生物科技有限公司
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, corticosteroid hormones and their compound preparations with antibacterial drugs are mostly used clinically to treat infantile eczema, but long-term use can cause dependence and various adverse reactions, such as skin atrophy, telangiectasia, pigmentation, etc.
Moreover, since

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for treating infantile eczema, preparation, preparation method of preparation, and application of composition
  • Composition for treating infantile eczema, preparation, preparation method of preparation, and application of composition
  • Composition for treating infantile eczema, preparation, preparation method of preparation, and application of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Embodiment 1 provides a kind of preparation on the one hand, comprises active ingredient D, component A, component B, component C;

[0070] In parts by weight, the active ingredient D includes the following components: 1 part of fermented product filtrate of Saccharomyces mulsa, 0.45 parts of plant extract; extract, Coptis chinensis extract, white fresh root bark extract, Polygonum cuspidatum root extract, flat storage extract, herb extract, Sophora flavescens extract, the corresponding weight ratio is 1:1:1:1:1:1: 1:1:1.

[0071] In parts by weight, the component A includes the following components: 0.06 parts of EDTA-disodium, 3 parts of glycerin, 2 parts of butylene glycol, 0.03 parts of xanthan gum, 0.02 parts of low-acyl gellan gum, 0.02 parts of high-acyl gellan gum, 0.02 parts of glue, 90 parts of water;

[0072] In parts by weight, the component B includes the following components: 2 parts of glyceryl stearate citrate, 1 part of stearyl glycyrrhetinate, 0.5 pa...

Embodiment 2

[0081] Embodiment 2 provides a kind of preparation on the one hand, comprises active component D, component A, component B, component C;

[0082] In parts by weight, the active ingredient D includes the following components: 1 part of fermented product filtrate of Saccharomyces mulsatrix, 0.45 parts of plant extract; , sophora flavescens extract, peppermint extract, Phellodendron phellodendri extract, perilla leaf extract, Burnet elm extract, and Hedyotis diffusa extract, the corresponding weight ratio is 1:1:1:1:1: 1:1:1:1.

[0083] In parts by weight, the component A includes the following components: 0.06 parts of EDTA-disodium, 3 parts of glycerin, 2 parts of butylene glycol, 0.03 parts of xanthan gum, 0.02 parts of low-acyl gellan gum, 0.02 parts of high-acyl gellan gum, 0.02 parts of glue, 90 parts of water;

[0084] In parts by weight, the component B includes the following components: 2 parts of glyceryl stearate citrate, 1 part of stearyl glycyrrhetinate, 0.5 part of ...

Embodiment 3

[0088] Embodiment 3 provides a kind of preparation on the one hand, comprises active component D, component A, component B, component C;

[0089] In parts by weight, the active ingredient D includes the following components: 1 part of fermented product filtrate of Saccharomyces mulsatrix, 0.45 parts of plant extract; , Cortex Phellodendri extract, Sophora flavescens extract, Dandelion extract, Schizonepeta extract, Herba Atractylodis extract, Atractylodes atractylodes extract, the corresponding weight ratio is 5:3:5:5:5:5:5: 5:5.

[0090] In parts by weight, the component A includes the following components: 0.06 parts of EDTA-disodium, 3 parts of glycerin, 2 parts of butylene glycol, 0.03 parts of xanthan gum, 0.02 parts of low-acyl gellan gum, 0.02 parts of high-acyl gellan gum, 0.02 parts of glue, 90 parts of water;

[0091] In parts by weight, the component B includes the following components: 2 parts of glyceryl stearate citrate, 1 part of stearyl glycyrrhetinate, 0.5 p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a composition for treating infantile eczema, a preparation, a preparation method of the preparation, and an application of the pcomposition. The preparation comprises an activeingredient D, a component A, a component B and component C; the active ingredient D comprises, by weight, 1 part of a pitera fermentation product filtrate and 0.45 part of plant extract; and the component A comprises 0.06 part of EDTA-2Na, 3 parts of glycerin, 2 parts of butanediol, 0.03 part of xanthan gum, 0.02 part of low acyl gellan gum, 0.02 part of high acyl gellan gum and 90 parts of water. The piter fermentation product is combined with traditional Chinese medicine components having the efficacy of clearing heat and drying dampness to uniformly act on the eczema part of skins in orderto make the skins fully absorb medicines, so local vasoconstriction, congestion reduction and inflammation reduction are achieved, thereby symptoms of eczema are treated or alleviated.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a composition for treating infantile eczema, a preparation, a preparation method and application. Background technique [0002] Infant eczema is a common and frequently-occurring disease in dermatology. The motherland medicine calls it "milk ringworm" or "fetal sore". In recent years, it is believed that this disease is the infantile type of atopic dermatitis. It is a skin inflammation with obvious exudation tendency caused by various internal and external factors. According to the performance of skin lesions, eczema can be divided into three types: acute, subacute, and chronic. In mild cases, local erythema, papules, and secretions ooze out of the skin; in severe cases, erosion and itching are the main recurrent attacks, which cannot be cured for a long time, seriously affecting the health and normal development of infants and young children. [0003] At present, corticostero...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/86A61K36/78A61K36/756A61K36/75A61K36/748A61K36/739A61P17/00A61P17/04A61K36/064A61K35/64
CPCA61K35/64A61K36/064A61K36/234A61K36/284A61K36/288A61K36/355A61K36/489A61K36/534A61K36/535A61K36/538A61K36/539A61K36/704A61K36/708A61K36/718A61K36/739A61K36/748A61K36/75A61K36/756A61K36/78A61K36/86A61K35/63A61P17/00A61P17/04A61K2300/00
Inventor 杨爱岗吴泽宏
Owner 上海松皓生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap